e possibl effect consumpt anim feed contain aph 3 rsquo ii anim gut microflora one comment argu empir evid gather assess potenti effect modifi food anim gut microflora agenc awar inform aph 3 rsquo ii would affect anim gut microflora differ protein diet comment provid inform comment may refer theoret potenti aph 3 rsquo ii anim feed affect efficaci neomycin administ anim theoret potenti gut microflora take kan r gene becom resist neomycin discuss likelihood transfer kan r gene gut microflora food anim extrem remot also discuss fda evalu studi present calgen address possibl inactiv neomycin aph 3 rsquo ii anim feed conclud therapeut efficaci neomycin anim would affect consumpt feed contain transgen cottonse rapese modifi use kan r gene f label food contain kan r gene aph 3 rsquo ii one comment assert aph 3 rsquo ii label ingredi comment state fda exempt aph 3 rsquo ii ingredi label requir base classif process aid present insignific level finish food technic function effect food fda requir special label ingest food contain aph 3 rsquo ii could compromis clinic efficaci oral administ kanamycin neomycin fda author food label base section 403 act 21 u c 343 section 403 act requir case food fabric two ingredi food product bear label common usual name ingredi unless complianc requir label impractic result decept unfair competit fda consid ingredi substanc use fabric e manufactur produc food fda consid substanc inher compon food ingredi must disclos food label genet substanc introduc plant breed becom inher part plant well food deriv plant consist fda gener approach ingredi label agenc treat ingredi new constitu plant introduc breed regardless method use develop new plant varieti comment provid basi fda deviat current practic case aph 3 rsquo ii 8 accordingli fda determin neither kan r gene aph 3 rsquo ii ingredi section 403 act must individu identifi label food contain footnot footnam 8 footnam furthermor aph 3 rsquo ii satisfi definit process aid 101 100 3 ii c 21 cfr 101 100 3 ii c regul final rule comment acknowledg fda label regul exempt process aid like aph 3 rsquo ii label requir section 403 2 act thu even aph 3 rsquo ii properli consid ingredi presenc food would requir disclos food label footnot fda also determin presenc aph 3 rsquo ii materi fact must disclos label food contain enzym section 403 1 act 21 u c 343 1 food misbrand label fals mislead section 201 n act 21 u c 321 n label mislead fail reveal fact materi respect consequ may result use articl discuss length fda determin ingest food contain aph 3 rsquo ii compromis clinic efficaci oral administ kanamycin neomycin consequ alleg comment_compromis clinic efficacy_wil occur presenc aph 3 rsquo ii materi fact requir disclosur v conclus fda evalu data petit relev materi conclud propos use aph 3 rsquo ii process aid develop new varieti tomato oilse rape cotton safe 21 cfr part 173 573 amend set forth vi inspect document accord 171 1 h 571 1 h 21 cfr 171 1 h 571 1 h petit document fda consid reli upon reach decis approv petit avail inspect center food safeti appli nutrit appoint inform contact person list provid 21 cfr 171 1 h 571 1 h agenc delet document materi avail public disclosur make document avail inspect